Finance
Cancer Prevention
Health
Enochian Biosciences
$7.169876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$7.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.01 (-0.14%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell ENOB and other stocks, options, ETFs, and crypto commission-free!
About
Enochian Biosciences, Inc. engages in the development of vaccine for treatment of infectious diseases and cancer. Its pipeline consists of ENO-1001, ENO-2001, ENO-3001, ENO-4002 and ENO-4001. Read More The company was founded by Rene Sindlev on January 18, 2011 and is headquartered in Horsholm, Denmark. ENOB is listed on the OTCQB market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).
Employees
4
Headquarters
Los Angeles, California
Founded
2011
Market Cap
278.12M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
27.38K
High Today
$7.25
Low Today
$6.95
Open Price
$7.20
Volume
35.17K
52 Week High
$9.50
52 Week Low
$3.32
Collections
Finance
Cancer Prevention
Health
2018 IPO
US
North America
Price Paid on Robinhood
4% Lower
Right Now
52 Week Low
$3.32
Average Price Paid
$7.44
52 Week High
$9.50
Earnings
Q4 2018
Q1 2019
Estimated
—
Actual
Expected May 15, After Hours